EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Increases in Hepatitis C Virus (HCV) Treatment and Cure Among People Who Inject Drugs in the Seattle Area Between 2018 and 2022

Jenni L Ebersberger, Judith I Tsui, Maria A Corcorran, Sara N Glick

AIDS and Behavior · 2026

DOI: 10.1007/s10461-026-05110-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift AIDS and Behavior, 2026. Verfasst von Jenni L Ebersberger und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Washington School of Medicine, Seattle, WA, USA. ebersberger10j@gmail.com. Hauptthemen laut MEDLINE: Substance Abuse, Intravenous, Hepatitis C, Continuity of Patient Care, Drug Users. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CDC HHS, JG CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to describe the current hepatitis C virus (HCV) continuum of care and characterize the prevalence of HCV among Seattle-area people who inject drugs (PWID), including an assessment of changes between 2018 and 2022. Cross-sectional data from the 2018 and 2022 Seattle-area National HIV Behavioral Surveillance (NHBS) surveys of PWID was included in this study. All participants completed a biobehavioral survey and were offered rapid HIV and HCV antibody testing. Among those who screened HCV antibody-positive, we estimated proportions for steps along the HCV care continuum, including proportions of PWID who had previously been told they had HCV, were treated, and cured. The 2018 and 2022 NHBS-PWID surveys included 533 and 495 participants, respectively. In 2022, 61% (303/495) of PWID tested HCV antibody-positive, compared with 71% (376/533) in 2018. Among those who were HCV antibody-positive, prior HCV testing was common in both years [94% (95% CI: 91%-96%) in 2018; 92% (95% CI: 89%-95%) in 2022]. The proportion reporting prior HCV diagnosis increased from 68% (95% CI: 63%-72%) in 2018 to 71% (95% CI: 66%-76%) in 2022. Among those diagnosed, treatment rose from 26% (95% CI: 20%-31%) in 2018 to 47% (95% CI: 40%-54%) in 2022, and cure increased from 18% (95% CI: 14%-23%) in 2018 to 33% (95% CI: 27%-40%) in 2022. Compared to 2018, in 2022 the proportion of PWID with HCV in the Seattle area who had been treated and cured nearly doubled. Sustained investment in HCV diagnosis and treatment is needed to strengthen the HCV continuum of care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse, IntravenousHepatitis CContinuity of Patient CareDrug UsersHumansWashingtonCross-Sectional StudiesFemaleAdultPrevalenceMaleHepacivirusMiddle AgedHIV Infections

Stichwörter der Autor:innen

Continuum of careHCV testingHCV treatmentHepatitis C virus (HCV)People who inject drugs

Autor:innen und Institutionen

  • University of Washington School of Medicine, Seattle, WA, USA. ebersberger10j@gmail.com.
  • Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Public Health - Seattle & King County, HIV/STI/HCV Program, Seattle, WA, USA.

Förderung

  • CDC HHS
  • JG CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Ebersberger, J. L., Tsui, J. I., Corcorran, M. A., & Glick, S. N. (2026). Increases in Hepatitis C Virus (HCV) Treatment and Cure Among People Who Inject Drugs in the Seattle Area Between 2018 and 2022. AIDS and Behavior. https://doi.org/10.1007/s10461-026-05110-9

Vancouver

Ebersberger JL, Tsui JI, Corcorran MA, Glick SN. Increases in Hepatitis C Virus (HCV) Treatment and Cure Among People Who Inject Drugs in the Seattle Area Between 2018 and 2022. AIDS and Behavior. 2026. doi:10.1007/s10461-026-05110-9

BibTeX
@article{Ebersberger2026,
  author = {Ebersberger, Jenni L and Tsui, Judith I and Corcorran, Maria A and Glick, Sara N},
  title = {Increases in Hepatitis C Virus (HCV) Treatment and Cure Among People Who Inject Drugs in the Seattle Area Between 2018 and 2022},
  journal = {AIDS and Behavior},
  year = {2026},
  doi = {10.1007/s10461-026-05110-9}
}
Kostenlos starten →